Bicara Therapeutics Inc. Common Stock (BCAX)
US$ 16.555.08%
Price Chart
Key Statistics
Market Cap
$ 900.58M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
702.11K
52W High
$ 28.09
52W Low
$ 8.91
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
25.244
200-Day MA
25.244
52 Week High
28.09
52 Week Low
8.91
About BCAX
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
Employees
55
Headquarters
Boston, MA
CEO
Ms. Claire Mazumdar Clemon M.B.A., Ph.D.
Latest News
Pentair To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
4 days ago • Google News
We Think Bicara Therapeutics (NASDAQ:BCAX) Can Afford To Drive Business Growth - simplywall.st
2025-03-13 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg